239 related articles for article (PubMed ID: 25563312)
21. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
Liu S; Pavan-Langston D; Colby KA
Ophthalmology; 2012 Oct; 119(10):2003-8. PubMed ID: 22796308
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Topical Ganciclovir and Corticosteroids Preserve Corneal Endothelial Function in Cytomegalovirus Corneal Endotheliitis.
Fan NW; Chung YC; Liu YC; Liu CJ; Kuo YS; Lin PY
Cornea; 2016 May; 35(5):596-601. PubMed ID: 26967107
[TBL] [Abstract][Full Text] [Related]
23. Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts.
Simon AL; Pavan-Langston D
Ophthalmology; 1996 Sep; 103(9):1399-404; discussion 1404-5. PubMed ID: 8841297
[TBL] [Abstract][Full Text] [Related]
24. Clinical translation of recommendations from randomized trials for management of herpes simplex virus keratitis.
Cabrera-Aguas M; Robaei D; McCluskey P; Watson S
Clin Exp Ophthalmol; 2018 Dec; 46(9):1008-1016. PubMed ID: 29749113
[TBL] [Abstract][Full Text] [Related]
25. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
[TBL] [Abstract][Full Text] [Related]
26. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
27. Management of herpes simplex virus epithelial keratitis.
Roozbahani M; Hammersmith KM
Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435
[TBL] [Abstract][Full Text] [Related]
28. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group.
Arch Ophthalmol; 1996 Sep; 114(9):1065-72. PubMed ID: 8790090
[TBL] [Abstract][Full Text] [Related]
29. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis.
Vajpayee RB; Dhakal BP; Gupta SK; Sachdev MS; Satpathy G; Honavar SG; Panda A
Aust N Z J Ophthalmol; 1996 May; 24(2):131-5. PubMed ID: 9199744
[TBL] [Abstract][Full Text] [Related]
32. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.
Wilhelmus KR; Dawson CR; Barron BA; Bacchetti P; Gee L; Jones DB; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA
Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723
[TBL] [Abstract][Full Text] [Related]
34. Altering clinical features of recurrent herpes simplex virus-induced keratitis.
Uchio E; Hatano H; Ohno S
Ann Ophthalmol; 1993 Jul; 25(7):271-6. PubMed ID: 8395784
[TBL] [Abstract][Full Text] [Related]
35. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis.
Wilhelmus KR; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Barron BA; Kaufman HE; Sugar J; Hyndiuk RA
Ophthalmology; 1994 Dec; 101(12):1883-95; discussion 1895-6. PubMed ID: 7997324
[TBL] [Abstract][Full Text] [Related]
36. Acyclovir-Resistant Herpes Simplex Virus 1 Keratitis: A Concerning and Emerging Clinical Challenge.
Rousseau A; Pharm SB; Gueudry J; Deback C; Haigh O; Schweitzer C; Boutolleau D; Labetoulle M
Am J Ophthalmol; 2022 Jun; 238():110-119. PubMed ID: 35033543
[TBL] [Abstract][Full Text] [Related]
37. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
38. Recurrence of herpes simplex virus endotheliitis in a Descemet membrane endothelial keratoplasty graft: mimicking fungal interface infection.
Basak SK; Basak S
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31064790
[TBL] [Abstract][Full Text] [Related]
39. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.
N Engl J Med; 1998 Jul; 339(5):300-6. PubMed ID: 9696640
[TBL] [Abstract][Full Text] [Related]
40. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
